NO884835L - Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-furo-og-tieno (2,3.-c)pyridiner. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-furo-og-tieno (2,3.-c)pyridiner.Info
- Publication number
- NO884835L NO884835L NO88884835A NO884835A NO884835L NO 884835 L NO884835 L NO 884835L NO 88884835 A NO88884835 A NO 88884835A NO 884835 A NO884835 A NO 884835A NO 884835 L NO884835 L NO 884835L
- Authority
- NO
- Norway
- Prior art keywords
- general formula
- compounds
- hydrogen
- branched
- carbon atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873736664 DE3736664A1 (de) | 1987-10-29 | 1987-10-29 | Tetrahydro-furo- und -thieno(2,3-c)pyridine, ihre verwendung als arzneimittel und verfahren zu ihrer herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO884835D0 NO884835D0 (no) | 1988-10-28 |
| NO884835L true NO884835L (no) | 1989-05-02 |
Family
ID=6339349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO88884835A NO884835L (no) | 1987-10-29 | 1988-10-28 | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-furo-og-tieno (2,3.-c)pyridiner. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0314154A3 (cs) |
| JP (1) | JPH01157983A (cs) |
| KR (1) | KR890006650A (cs) |
| AU (1) | AU2443588A (cs) |
| CS (1) | CS273193B2 (cs) |
| DD (1) | DD283395A5 (cs) |
| DE (1) | DE3736664A1 (cs) |
| DK (1) | DK603588A (cs) |
| FI (1) | FI884947L (cs) |
| HU (1) | HU201553B (cs) |
| IL (1) | IL88184A0 (cs) |
| NO (1) | NO884835L (cs) |
| PL (1) | PL275555A1 (cs) |
| PT (1) | PT88899B (cs) |
| SU (1) | SU1657064A3 (cs) |
| YU (1) | YU201288A (cs) |
| ZA (1) | ZA888089B (cs) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2623810B2 (fr) * | 1987-02-17 | 1992-01-24 | Sanofi Sa | Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant |
| US5272148A (en) * | 1992-09-09 | 1993-12-21 | Hoechst-Roussel Pharmaceuticals Incorporated | Heteroarenylpiperazines |
| US8914114B2 (en) | 2000-05-23 | 2014-12-16 | The Feinstein Institute For Medical Research | Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
| KR20130118395A (ko) * | 2000-07-06 | 2013-10-29 | 다이이찌 산쿄 가부시키가이샤 | 히드로피리딘 유도체 산부가염 |
| EP1487494A2 (en) * | 2002-02-26 | 2004-12-22 | North Shore-Long Island Jewish Research Institute | Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| WO2005092308A2 (en) | 2004-03-25 | 2005-10-06 | The Feinstein Institute For Medical Research | Neural tourniquet |
| US10912712B2 (en) | 2004-03-25 | 2021-02-09 | The Feinstein Institutes For Medical Research | Treatment of bleeding by non-invasive stimulation |
| US11207518B2 (en) | 2004-12-27 | 2021-12-28 | The Feinstein Institutes For Medical Research | Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway |
| WO2006073484A2 (en) | 2004-12-27 | 2006-07-13 | North Shore-Long Island Jewish Research Institute | Treating inflammatory disorders by electrical vagus nerve stimulation |
| TWI392681B (zh) * | 2006-04-06 | 2013-04-11 | Daiichi Sankyo Co Ltd | 高純度普拉格雷及其酸加成鹽之製法 |
| RU2435776C2 (ru) * | 2007-03-02 | 2011-12-10 | Дайити Санкио Компани, Лимитед | Способ получения высокочистого празугрель гидрохлорида |
| WO2009029614A1 (en) | 2007-08-27 | 2009-03-05 | The Feinstein Institute For Medical Research | Devices and methods for inhibiting granulocyte activation by neural stimulation |
| WO2009146030A1 (en) | 2008-03-31 | 2009-12-03 | The Feinstein Institute For Medical Research | Methods and systems for reducing inflammation by neuromodulation of t-cell activity |
| US9662490B2 (en) | 2008-03-31 | 2017-05-30 | The Feinstein Institute For Medical Research | Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug |
| US9211410B2 (en) | 2009-05-01 | 2015-12-15 | Setpoint Medical Corporation | Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation |
| US8996116B2 (en) | 2009-10-30 | 2015-03-31 | Setpoint Medical Corporation | Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction |
| WO2010144578A2 (en) | 2009-06-09 | 2010-12-16 | Setpoint Medical Corporation | Nerve cuff with pocket for leadless stimulator |
| WO2014169145A1 (en) | 2013-04-10 | 2014-10-16 | Setpoint Medical Corporation | Closed-loop vagus nerve stimulation |
| US9833621B2 (en) | 2011-09-23 | 2017-12-05 | Setpoint Medical Corporation | Modulation of sirtuins by vagus nerve stimulation |
| EP2515996B1 (en) | 2009-12-23 | 2019-09-18 | Setpoint Medical Corporation | Neural stimulation devices and systems for treatment of chronic inflammation |
| WO2012154865A2 (en) | 2011-05-09 | 2012-11-15 | Setpoint Medical Corporation | Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation |
| US12172017B2 (en) | 2011-05-09 | 2024-12-24 | Setpoint Medical Corporation | Vagus nerve stimulation to treat neurodegenerative disorders |
| US9572983B2 (en) | 2012-03-26 | 2017-02-21 | Setpoint Medical Corporation | Devices and methods for modulation of bone erosion |
| US11311725B2 (en) | 2014-10-24 | 2022-04-26 | Setpoint Medical Corporation | Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation |
| US11406833B2 (en) | 2015-02-03 | 2022-08-09 | Setpoint Medical Corporation | Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator |
| US10596367B2 (en) | 2016-01-13 | 2020-03-24 | Setpoint Medical Corporation | Systems and methods for establishing a nerve block |
| EP3405255A4 (en) | 2016-01-20 | 2019-10-16 | Setpoint Medical Corporation | IMPLANTABLE MICROSTIMULATORS AND INDUCTIVE CHARGING SYSTEMS |
| US11471681B2 (en) | 2016-01-20 | 2022-10-18 | Setpoint Medical Corporation | Batteryless implantable microstimulators |
| CN108882885A (zh) | 2016-01-20 | 2018-11-23 | 赛博恩特医疗器械公司 | 迷走神经刺激的控制 |
| US10583304B2 (en) | 2016-01-25 | 2020-03-10 | Setpoint Medical Corporation | Implantable neurostimulator having power control and thermal regulation and methods of use |
| US11173307B2 (en) | 2017-08-14 | 2021-11-16 | Setpoint Medical Corporation | Vagus nerve stimulation pre-screening test |
| US11260229B2 (en) | 2018-09-25 | 2022-03-01 | The Feinstein Institutes For Medical Research | Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation |
| WO2020210786A1 (en) | 2019-04-12 | 2020-10-15 | Setpoint Medical Corporation | Vagus nerve stimulation to treat neurodegenerative disorders |
| EP4566539A1 (en) | 2020-05-21 | 2025-06-11 | The Feinstein Institutes for Medical Research | Systems and methods for vagus nerve stimulation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2315274A1 (fr) * | 1975-06-27 | 1977-01-21 | Parcor | Nouveaux derives de la thieno (2,3-c) pyridine, leur preparation et leurs applications |
| FR2317303A1 (fr) * | 1975-07-09 | 1977-02-04 | Parcor | Procede de preparation de derives de la tetrahydrothieno (3,2-c) et (2,3-c) pyridine |
-
1987
- 1987-10-29 DE DE19873736664 patent/DE3736664A1/de not_active Withdrawn
-
1988
- 1988-10-27 IL IL88184A patent/IL88184A0/xx unknown
- 1988-10-27 CS CS712688A patent/CS273193B2/cs unknown
- 1988-10-27 DD DD88321141A patent/DD283395A5/de not_active IP Right Cessation
- 1988-10-27 YU YU02012/88A patent/YU201288A/xx unknown
- 1988-10-27 FI FI884947A patent/FI884947L/fi not_active IP Right Cessation
- 1988-10-28 PT PT88899A patent/PT88899B/pt not_active IP Right Cessation
- 1988-10-28 JP JP63272853A patent/JPH01157983A/ja active Pending
- 1988-10-28 NO NO88884835A patent/NO884835L/no unknown
- 1988-10-28 PL PL27555588A patent/PL275555A1/xx unknown
- 1988-10-28 SU SU884356747A patent/SU1657064A3/ru active
- 1988-10-28 ZA ZA888089A patent/ZA888089B/xx unknown
- 1988-10-28 AU AU24435/88A patent/AU2443588A/en not_active Abandoned
- 1988-10-28 KR KR1019880014063A patent/KR890006650A/ko not_active Withdrawn
- 1988-10-28 EP EP19880117961 patent/EP0314154A3/de not_active Withdrawn
- 1988-10-28 DK DK603588A patent/DK603588A/da not_active Application Discontinuation
- 1988-10-28 HU HU885642A patent/HU201553B/hu not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT88899B (pt) | 1993-01-29 |
| FI884947A0 (fi) | 1988-10-27 |
| FI884947A7 (fi) | 1989-04-30 |
| EP0314154A3 (de) | 1990-12-05 |
| NO884835D0 (no) | 1988-10-28 |
| DD283395A5 (de) | 1990-10-10 |
| YU201288A (en) | 1990-08-31 |
| DK603588D0 (da) | 1988-10-28 |
| DE3736664A1 (de) | 1989-05-11 |
| HU201553B (en) | 1990-11-28 |
| AU2443588A (en) | 1989-07-13 |
| EP0314154A2 (de) | 1989-05-03 |
| IL88184A0 (en) | 1989-06-30 |
| ZA888089B (en) | 1990-07-25 |
| FI884947L (fi) | 1989-04-30 |
| SU1657064A3 (ru) | 1991-06-15 |
| PL275555A1 (en) | 1989-05-02 |
| CS712688A2 (en) | 1990-06-13 |
| HUT50824A (en) | 1990-03-28 |
| CS273193B2 (en) | 1991-03-12 |
| DK603588A (da) | 1989-04-30 |
| KR890006650A (ko) | 1989-06-15 |
| JPH01157983A (ja) | 1989-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO884835L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-furo-og-tieno (2,3.-c)pyridiner. | |
| US6800650B2 (en) | Pyridine and quinoline derivatives | |
| US6486153B1 (en) | Phenylindole derivatives as 5-HT2A receptor ligands | |
| US9045428B2 (en) | Substituted heterocyclic compounds | |
| EP0086422B1 (en) | Pharmacologically active pyrazolo(4,3-c)pyridines | |
| TWI424846B (zh) | 可作為ｄ3／ｄ2拮抗劑之新穎哌嗪鹽類 | |
| JPH03181461A (ja) | 抗不整脈剤 | |
| CN105814022A (zh) | 作为tnf活性调节剂的稠合的二环杂芳族衍生物 | |
| WO1994014801A1 (en) | Heterocyclic urea derivatives as 5ht2c and 5ht2b antagonists | |
| JPH0784462B2 (ja) | ベンゾイミダゾ−ル誘導体 | |
| EP0906301A1 (en) | Benzofuryl derivatives and their use | |
| JPH01249769A (ja) | 向精神性ヘテロビシクロアルキルピペラジン誘導体 | |
| EP1567528A1 (en) | Mixed lineage kinase modulators | |
| US11236083B2 (en) | Compounds and pharmaceutical compositions for modulating SGK activity, and methods thereof | |
| US5594001A (en) | Polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders | |
| SK280356B6 (sk) | Metanoantracénové deriváty, spôsob ich prípravy, m | |
| HU191161B (en) | Process for production of derivatives of tieno /2,2-a/ piramidin and their salts | |
| AU690906B2 (en) | Novel polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disoders | |
| Bilokin et al. | A novel and expedient approach to new heterocycles containing benzothiophene, benzothieno [2, 3-d] pyrimidine and coumarin moieties | |
| JP3044055B2 (ja) | １，２―エタンジオール誘導体およびその塩 | |
| NO772473L (no) | Fremgangsm}te ved fremstilling av nye thieno (2,3-c) og (3,2-c) pyridiner | |
| WO2024130425A9 (en) | Methods of making 2-amino-1-(3-hydroxy-2,6-dimethylphenyl)-5,6- dimethyl-1h-pyrrolo-[2,3-b]pyridine-3-carboxamide, a myt1 inhibitor | |
| SK4572000A3 (en) | 2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d) | |
| WO2010059555A1 (en) | Prolyl hydroxylase inhibitors | |
| WO2005100355A1 (ja) | 環状アミン化合物 |